Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Laslop

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Seminars in Arthritis and Rheumatism|August 9, 2005
Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in ScienceEric C Abadie, Jean-Pierre Devogealer, Johann D Ringe, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 11, 2005
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in menJean-Yves Reginster, Eric Abadie, Pierre Delmas, et al.
Aging Clinical and Experimental Research|May 23, 2023
Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric propertiesCharlotte Beaudart, Jean-Yves Reginster, Jotheeswaran Amuthavalli Thiyagarajan, et al.
Bone|June 12, 2008
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosisJörg Goldhahn, Wim H Scheele, Bruce H Mitlak, et al.
Advances in Therapy|August 24, 2019
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for OsteoporosisMattias Lorentzon, Jaime Branco, Maria Luisa Brandi, et al.
Calcified Tissue International|May 18, 2019
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.
Seminars in Arthritis and Rheumatism|September 3, 2013
Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)Mickaël Hiligsmann, Cyrus Cooper, Nigel Arden, et al.
Current Medical Research and Opinion|December 15, 2010
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RAJosef S Smolen, Maarten Boers, Eric C Abadie, et al.
Seminars in Arthritis and Rheumatism|December 31, 2017
Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Jean-Yves L Reginster, Nigel K Arden, Ida K Haugen, et al.
The Lancet. Healthy Longevity|November 17, 2023
Inclusion of functional measures and frailty in the development and evaluation of medicines for older adultsMichael Denkinger, Wilma Knol, Antonio Cherubini, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Seminars in Arthritis and Rheumatism|August 9, 2005
Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in ScienceEric C Abadie, Jean-Pierre Devogealer, Johann D Ringe, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 11, 2005
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in menJean-Yves Reginster, Eric Abadie, Pierre Delmas, et al.
Aging Clinical and Experimental Research|May 23, 2023
Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric propertiesCharlotte Beaudart, Jean-Yves Reginster, Jotheeswaran Amuthavalli Thiyagarajan, et al.
Bone|June 12, 2008
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosisJörg Goldhahn, Wim H Scheele, Bruce H Mitlak, et al.
Advances in Therapy|August 24, 2019
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for OsteoporosisMattias Lorentzon, Jaime Branco, Maria Luisa Brandi, et al.
Calcified Tissue International|May 18, 2019
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.
Seminars in Arthritis and Rheumatism|September 3, 2013
Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)Mickaël Hiligsmann, Cyrus Cooper, Nigel Arden, et al.
Current Medical Research and Opinion|December 15, 2010
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RAJosef S Smolen, Maarten Boers, Eric C Abadie, et al.
Seminars in Arthritis and Rheumatism|December 31, 2017
Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Jean-Yves L Reginster, Nigel K Arden, Ida K Haugen, et al.
The Lancet. Healthy Longevity|November 17, 2023
Inclusion of functional measures and frailty in the development and evaluation of medicines for older adultsMichael Denkinger, Wilma Knol, Antonio Cherubini, et al.
Pageof 5